Offstream
news

---

Changes

1. The Swiss government signs a deal to reserve 8,640 doses of the Merck & Co. antiviral drug molnupiravir, with the said drug should be available at least January 2022.
   2021-11-24 03:06:28 (First version)
2. The Swiss government signs a deal to reserve 8,640 doses of Merck & Co.'s antiviral drug molnupiravir beginning in January.
   (Current version)

---

Related

It is announced that Merck & Co.'s antiviral drug molnupiravir will be available to Philippine patients after the Food and Drug Administration issued a compassionate special permit for the drug and an agreement was signed between the Office of the Vice President of the Philippines and a local health care provider.
2021-11-24

Sri Lanka approves the use of the COVID-19 oral drug molnupiravir in the country.
2021-11-15

The government announces that they will obtain 1.6 million doses of Merck & Co.'s molnupiravir and have also increased hospital capacities for COVID-19 patients to 30% in order to prepare for a sixth wave of the pandemic.
2021-11-12

The Medicines and Healthcare products Regulatory Agency grants conditional authorisation to Merck's molnupiravir, which can be used to treat symptomatic COVID-19 patients, making the United Kingdom the first country to approve the world's first COVID-19 antiviral oral drug.
2021-11-4

Merck & Co. signs a licensing agreement with the UN-backed Medicines Patent Pool that will allow more companies to manufacture generic versions of its experimental oral antiviral COVID-19 treatment molnupiravir with a royalty-free license that will apply to 105 low- and middle-income countries.
2021-10-27

The British government signs an agreement to secure 480,000 courses of Molnupiravir produced by Merck Sharp and Dohme, and 250,000 courses of Ritonavir produced by Pfizer, where both of them need to be approved by health regulator.
2021-10-20

Malaysia signs an agreement with Merck & Co. to obtain 150,000 courses of the experimental drug Molnupiravir as part of a transition towards the endemic phase and "living with the COVID-19".
2021-10-7

The Australian government signs an agreement with Merck Sharp & Dohme to buy 300,000 courses of the antiviral drug molnupiravir, pending regulator clearance, which would be the first pill to treat COVID-19 patients.
2021-10-4

U.S. President Joe Biden announces that Merck & Co. will produce single-shot Johnson & Johnson vaccine to help his administration goal for vaccinating every adult by the end of May.
2021-03-2

Oregon reports 24 new deaths in the past 24 hours, a new single-day record since the pandemic began.
2020-12-1